The role of living donor liver transplantation in treating intrahepatic cholangiocarcinoma
Open Access
- 21 May 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1404683
Abstract
Introduction: Intrahepatic cholangiocarcinoma (iCC) is the liver’s second most common neoplasm. Until now, surgery is the only curative option, but only 35% of the cases are considered resectable at the diagnosis, with a post-resection survival of around 30%. Advancements in surgical techniques and perioperative care related to liver transplantation (LT) have facilitated the expansion of indications for hepatic neoplasms.Method: This study is a comprehensive review of the global experience in living donor LT (LDLT) for treating iCC and describes our first case of LDLT for an unresectable iCC.Results: While exploring LT for intrahepatic cholangiocarcinoma dates to the 1990s, the initial outcomes were discouraging, marked by poor survival and high recurrence rates. Nevertheless, contemporary perspectives underscore a reinvigorated emphasis on extending the frontiers of LT indications within the context of the “oncologic era.” The insights gleaned from examining explants, wherein incidental iCC was categorized as hepatocellular carcinoma in the preoperative period, have demonstrated comparable survival rates to small hepatocellular carcinoma. These findings substantiate the potential viability of LT as a curative alternative for iCC. Another investigated scenario pertains to “unresectable tumors with favorable biological behavior,” LT presents a theoretical advantage by providing free margins without the concern of a small future liver remnant. The constraint of organ shortage persists, particularly in nations with low donation rates. LDLT emerges as a viable and secure alternative for treating iCC.Conclusion: LDLT is an excellent option for augmenting the graft pool, particularly in carefully selected patients.Keywords
This publication has 43 references indexed in Scilit:
- Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular CarcinomaJAMA Surgery, 2022
- Living donor liver transplantation for intra hepatic cholangiocarcinomaAnnals of Medicine & Surgery, 2020
- Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of CirrhosisLiver Transplantation, 2020
- Barriers and Limitations to Access to Liver Transplantation in Latin AmericaClinical Liver Disease, 2019
- Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)Liver Transplantation, 2018
- Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessmentHepatology, 2016
- Can hepatic resection provide a long‐term cure for patients with intrahepatic cholangiocarcinoma?Cancer, 2015
- Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar CholangiocarcinomaArchives of Surgery, 2011
- Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinomaLiver Transplantation, 2011
- Living-donor liver transplantation for Caroli's disease with intrahepatic adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2001